Flaws in advance directives that request withdrawing assisted feeding in late-stage dementia may cause premature or prolonged dying

Author:

Terman Stanley A.ORCID,Steinberg Karl E.,Hinerman Nathaniel

Abstract

AbstractBackgroundThe terminal illness of late-stage (advanced) Alzheimer’s and related dementias is progressively cruel, burdensome, and can last years if caregivers assist oral feeding and hydrating. Options to avoid prolonged dying are limited since advanced dementia patients cannot qualify for Medical Aid in Dying. Physicians and judges can insist on clear and convincing evidence that the patient wants to die—which many advance directives cannot provide. Proxies/agents’ substituted judgment may not be concordant with patients’ requests. While advance directives can be patients’ last resort to attain a peaceful and timely dying consistent with their lifelong values, success depends on their being effective and acceptable. A single flaw can provide opponents justification to refuse the directive’s requests to cease assisted feeding.AimThis article considers 24 common advance directive flaws in four categories.Process flawsfocus on how patients express their end-of-life wishes.Content flawsreflect drafters’ selection of conditions and interventions, and how they are described.Inherent flawscan make advance directives unacceptable to authorities concerned about premature dying.Strategiesare needed to compel physicians to write needed orders and to prevent third parties from sabotaging these orders after they are  implemented. The article includes excerpts from “dementia-specific” directives or supplements that exemplify each flaw—mostly from the US and Europe. No directive critiqued here included an effectivestrategyto resolve this long-debated bioethical conflict: the past directive requests “Cease assisted feeding” but the incapacitated patient apparently expresses the desire to “Continue assisted feeding.” Some opponents to the controversial request, cease assisted feeding, use this conflict as a conceptual wedge to practice hard paternalism. This article proposes a protocol to prevent this conflict from emerging. These strategies may prevent authorities from requiring patients to fulfillauthorities’additional clinical criteria as a prerequisite to honor the requests in patients directives.ConclusionThis critique of flaws may serve as a guide to drafting and to selecting effective and acceptable advance directives for dementia. It also poses several bioethical and clinical questions to those in authority: Does your paternalistic refusal to honor patients’ wishes respect their self-determination? Protect vulnerable patients from harm? Force patients to endure prolonged suffering? Violate the principles of bioethics? Violate the very foundation of patient-centered care?

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Health (social science),Issues, ethics and legal aspects

Reference104 articles.

1. Alzheimer’s Society. Over half of people fear dementia diagnosis, 62 per cent think it means “life is over.” 2019. https://www.alzheimers.org.uk/news/2018-05-29/over-half-people-fear-dementia-diagnosis-62-cent-think-it-means-life-over. Accessed 23 Jan 2021.

2. Alzheimer’s Association. 2018 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia. 2018;14(3):367–429.

3. The Lewin Group Model (2015). Changing the trajectory of Alzheimer’s disease: a national imperative. Appendix B. Current Trajectory. https://www.alz.org/media/documents/changing-the-trajectory-r.pdf Accessed 11 Sept. 2020. https://www.alz.org/documents_custom/Trajectory_Appendix_B.pdf (No longer accessible.)

4. Khachaturian, Z. Years of Alzheimer’s Research Failure: Now what? Medpage Today (40). September 13, 2018. https://www.medpagetoday.com/neurology/alzheimersdisease/75075. Accessed 14 May 2022.

5. https://arstechnica.com/science/2021/06/a-disgraceful-decision-researchers-blast-fda-for-approving-alzheimers-drug/ Accessed 14 May 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3